Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125205971 | 12520597 | 1 | I | 20151003 | 20160601 | 20160701 | 20160701 | EXP | JP-ROCHE-1771800 | ROCHE | MATSUSHITA H, SAKURAGI S, KATAYAMA Y, ET AL. A CASE OF CARDIAC FAILURE DEVELOPING DURING ANTICANCER DRUG THERAPY FOR BREAST CANCER, WHICH LED TO TREATMENT DIFFICULTY.. PROCEEDINGS OF THE 114TH CHUGOKU REGIONAL MEETING OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE 2016 MAY 07;:-. | 64.00 | YR | F | Y | 0.00000 | 20160701 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125205971 | 12520597 | 1 | PS | AVASTIN | BEVACIZUMAB | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 125085 | SOLUTION FOR INFUSION | ||||||||
| 125205971 | 12520597 | 2 | SS | AVASTIN | BEVACIZUMAB | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 125085 | |||||||||
| 125205971 | 12520597 | 3 | SS | XELODA | CAPECITABINE | 1 | Oral | DOSAGE IS UNCERTAIN. | U | 20896 | TABLET | ||||||||
| 125205971 | 12520597 | 4 | SS | DOXORUBICIN HYDROCHLORIDE. | DOXORUBICIN HYDROCHLORIDE | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 0 | |||||||||
| 125205971 | 12520597 | 5 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 0 | |||||||||
| 125205971 | 12520597 | 6 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 0 | |||||||||
| 125205971 | 12520597 | 7 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous drip | DOSAGE IS UNCERTAIN. | U | 0 | |||||||||
| 125205971 | 12520597 | 8 | SS | DOBUTAMINE | DOBUTAMINEDOBUTAMINE HYDROCHLORIDE | 1 | Unknown | DOSAGE IS UNCERTAIN. | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125205971 | 12520597 | 1 | Breast cancer |
| 125205971 | 12520597 | 2 | Breast cancer |
| 125205971 | 12520597 | 3 | Breast cancer |
| 125205971 | 12520597 | 4 | Breast cancer |
| 125205971 | 12520597 | 5 | Breast cancer |
| 125205971 | 12520597 | 6 | Breast cancer |
| 125205971 | 12520597 | 7 | Breast cancer |
| 125205971 | 12520597 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125205971 | 12520597 | OT |
| 125205971 | 12520597 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125205971 | 12520597 | Cardiac failure | |
| 125205971 | 12520597 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125205971 | 12520597 | 1 | 201506 | 201508 | 0 | |
| 125205971 | 12520597 | 2 | 201509 | 0 | ||
| 125205971 | 12520597 | 3 | 201402 | 201403 | 0 | |
| 125205971 | 12520597 | 4 | 201308 | 201401 | 0 | |
| 125205971 | 12520597 | 5 | 201308 | 201401 | 0 | |
| 125205971 | 12520597 | 6 | 201401 | 201402 | 0 | |
| 125205971 | 12520597 | 7 | 201506 | 201508 | 0 |